ProKidney Announces Late‑Breaking Phase 2 REGEN‑007 Poster
ProKidney (Nasdaq: PROK) will present two posters at the American…
Using AI models to improve prediction of CKD’s progression to end-stage renal disease
Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…